Publications by authors named "Jean Benard"

Claim this Profile
I
Individual perception of environmental factors that influence lower limbs spasticity in inherited spastic paraparesis.
Pauline Lallemant-Dudek, Livia Parodi, Giulia Coarelli, Anna Heinzmann, Perrine Charles, Jean Benard

Ann Phys Rehabil Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable -Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
Inge M Ambros, Gian-Paolo Tonini, Ulrike Pötschger, Nicole Gross, Véronique Mosseri

J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the human polypeptide GalNAc-T1 and T13 paralogs.
María Florencia Festari, Felipe Trajtenberg, Nora Berois, Sergio Pantano, Leslie Revoredo

Glycobiology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.
Caroline Masserot, Qingyuan Liu, Eric Nguyen, Charles-Henry Gattolliat, Dominique Valteau-Couanet

Mol Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers.
André Oberthuer, Dilafruz Juraeva, Barbara Hero, Ruth Volland, Carolina Sterz

Clin Cancer Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.
Abdelkader Selmi, Maud de Saint-Jean, Anne-Catherine Jallas, Elisabeth Garin, Michael D Hogarty

Cancer Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma.
Benjamin Gibert, Céline Delloye-Bourgeois, Charles-Henry Gattolliat, Olivier Meurette, Solen Le Guernevel

J Natl Cancer Inst· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WNT5A encodes two isoforms with distinct functions in cancers.
Matthieu Bauer, Jean Bénard, Terry Gaasterland, Karl Willert, David Cappellen

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients.
Charles-Henry Gattolliat, Gwénaël Le Teuff, Valérie Combaret, Eugénie Mussard, Dominique Valteau-Couanet

Cancer Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[ROS1 fusion proteins, targets of foretinib].
Jean Bénard

Bull Cancer· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Explicative models of cancer biology: an enlarged vision].
Jean Bénard, Christian-Jacques Larsen

Bull Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
Nora Berois, Charles-Henry Gattolliat, Enrique Barrios, Laura Capandeguy, Sétha Douc-Rasy

Clin Chem· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant.
Mona Samy, Charles-Henry Gattolliat, Frédéric Pendino, Josette Hillion, Eric Nguyen

Mol Cancer Ther· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.
Franck Bourdeaut, Sandrine Ferrand, Laurence Brugières, Marjorie Hilbert, Agnès Ribeiro

Eur J Hum Genet· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chromosomal rearrangements and fusion genes in carcinoma].
Christophe Massard, Nathalie Auger, Ludovic Lacroix, Jean Bénard

Bull Cancer· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase II-alpha protein expression and histological response following doxorubicin-based induction chemotherapy predict survival of locally advanced soft tissues sarcomas.
Ruiz-Soto Rodrigo, Auger Nathalie, Tournay Elodie, Gomez-Abuin Gonzalo, Terrier Philippe

Eur J Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.
Anne Chauchereau, Nader Al Nakouzi, Catherine Gaudin, Sylvestre Le Moulec, Daniel Compagno

Exp Cell Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multilocus technique for risk evaluation of patients with neuroblastoma.
Inge M Ambros, Bettina Brunner, Gerhard Aigner, Clare Bedwell, Klaus Beiske

Clin Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[RB, guardian of prostatic tumor progression].
Jean Bénard, Christophe Massard

Bull Cancer· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma.
Xénia Mergui, Marie-Line Puiffe, Dominique Valteau-Couanet, Marc Lipinski, Jean Bénard

BMC Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of gene expression-based classification for neuroblastoma.
André Oberthuer, Barbara Hero, Frank Berthold, Dilafruz Juraeva, Andreas Faldum

J Clin Oncol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.
Sébastien Salas, Frederic Chibon, Tetsuro Noguchi, Philippe Terrier, Dominique Ranchere-Vince, Jean Benard

Genes Chromosomes Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells.
Karima Bettayeb, Dianne Baunbæk, Claire Delehouze, Nadège Loaëc, Alison J Hole

Genes Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis.
Jimena Bouzas-Rodriguez, Jorge Ruben Cabrera, Céline Delloye-Bourgeois, Gabriel Ichim, Jean-Guy Delcros

J Clin Invest· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.
Joëlle Vermeulen, Katleen De Preter, Arlene Naranjo, Liesbeth Vercruysse, Nadine Van Roy

Lancet Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis